King's brief lung disease questionnaire for interstitial lung disease
Part of Lungs & breathing clinical trials.
This study is testing a questionnaire that measures how interstitial lung disease affects your daily life. If you have been diagnosed with this condition by a rheumatologist, your answers will help doctors understand your symptoms better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with interstitial lung disease by a rheumatologist
- You are 18 years or older
- You agree to take part in the study
- You can speak and understand Turkish fluently
- You do not have heart failure that limits your daily activities
- You are not currently being treated for cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects health and breathing test information from adults with autoimmune-related lung scarring (interstitial lung disease) diagnosed recently. It helps researchers better understand who has this condition and how it changes over time.
This study checks whether a Turkish version of a symptom questionnaire works reliably for people with idiopathic pulmonary fibrosis. It may help clinics better understand symptoms and track changes over time.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This study uses ultrasound and sensors to monitor lung health in people with certain lung conditions, including those that cause scarring or breathing problems. It aims to find better ways to track lung disease, which could help manage your condition more effectively.
This is an observational (non-treatment) study that collects information about how interstitial lung disease (lung scarring) happens in people with certain autoimmune or immune-related conditions. It uses patient interviews or existing medical records to better understand the pattern and causes, which may help future care.
Hear when a new Interstitial Lung Disease Due to Systemic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.